QLB Biotherapeutics Inc., located in Boston, Massachusetts, is a startup biotechnology company focusing on discovering and developing biological therapeutics. QLB Bio is funded by Qilu Pharmaceutical, and will become its biggest overseas Research and Development Center. QLB Bio is devoted to developing next-generation cancer therapeutics using the transformative potential of immunotherapy. We have an ambitious vision and a growing pipeline of novel cancer immunotherapy biological candidates to treat solid tumors as well as hematologic cancers.